Company's Latest Solution Integrates Protocol Design, Document Generation, and Statistical Programming to Accelerate Trial Execution and Deliver Submission-ready Data "AI Conductor transforms clinical ...

ClinCapture announces AI-powered clinical trial build tech that automates study configuration, and advances intelligent ...

Clinical research organization uses AI agent-driven knowledge platform built on a unified contextual data layer to identify higher-performing trial sites ...

Phase 2 monotherapy trial of FG-3246, a potential first-in-class antibody drug conjugate (ADC) targeting CD46, in metastatic castration-resistant prostate cancer (mCRPC) is actively enrolling and rema ...

BACKGROUND: Premature atrial contractions (PACs) are independently associated with atrial fibrillation, stroke, and heart failure, yet no pharmacological therapy is approved for PAC suppression.

Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the future of gene editing.

Extended long-term survival observed after an additional year of follow-up in ongoing phase 2a clinical trial, with 50% of 46 patients with advanced non-small cell lung cancer (NSCLC) treated with ...

A potential cancer treatment is progressing. The post Which ASX biotech's shares have jumped more than 10% on positive clinical trial news? appeared first on The Motley Fool Australia.

Following the End-of-Phase 2 meeting with the FDA, the Company gained alignment on its Phase 3 program for the treatment of ...

More than 1,000 samples have been enrolled in the Pattern Bioscience clinical trial evaluating the Pattern Pneumonia ID/AST Panel and Pattern System ...

Need a quote from a Motley Fool analyst? The risks and uncertainties associated with the company's business are detailed in ...

AI Conductor operates as an orchestration layer across PhaseV’s vertical AI platform.